GABAergic influences on plus-maze behaviour in mice

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• GABAergic system's role in anxiety is complex, with variable effects observed in animal models.
• Understanding GABAergic modulation is crucial for developing effective anxiolytic treatments.

Purpose of the Study:

• To investigate the behavioral profiles of various GABA-related compounds in an ethological elevated plus-maze model.
• To elucidate the specific roles of GABAA and GABAB receptors in anxiety-related behaviors.

Main Methods:

• Utilized an ethological version of the murine elevated plus-maze.
• Administered diazepam, valproic acid, No-711, muscimol, (+)bicuculline, picrotoxin, R(+)baclofen, and CGP 35348 at various doses.
• Assessed both conventional and ethological behavioral indices.

Main Results:

• Diazepam, valproic acid (GABA-T inhibitor), and muscimol (GABAA agonist) demonstrated anxiolytic effects.
• GABA reuptake inhibitor No-711 showed weak anxiolytic effects at low doses but behavioral disruption at high doses.
• (+)bicuculline and picrotoxin (GABAA antagonists) induced anxiety-like changes, with dose-dependent behavioral suppression.
• R(+)baclofen (GABAB agonist) caused non-specific behavioral disruption at high doses; CGP 35348 (GABAB antagonist) was inactive.

Conclusions:

• The elevated plus-maze is sensitive to agents modulating GABAA receptor function.
• Valproic acid and direct GABAA receptor agonists/antagonists significantly influence anxiety-related behaviors.
• Further research is needed to fully characterize the complex relationship between GABAergic system manipulation and anxiety.